Prospective evaluation of serial 2-hydroxyglutarate in acute myeloid leukemia (AML) to determine response to therapy and predict relapse Meeting Abstract
| Authors: | Fathi, A. T.; Abdel-Wahab, O. I.; Sadrzadeh, H.; Foster, J.; Burke, M.; Borger, D. R.; Iafrate, A. J.; Adamia, S.; Liu, S.; Ballen, K. K.; Amrein, P. C.; Attar, E. C.; Straley, K.; Yen, K.; Schenkein, D. P.; Neuberg, D. S.; Levine, R. L.; Chen, Y. B. A.; Stone, R. M. |
| Abstract Title: | Prospective evaluation of serial 2-hydroxyglutarate in acute myeloid leukemia (AML) to determine response to therapy and predict relapse |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009802662 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.6606 |
| Notes: | Meeting Abstract: 6606 -- Source: Wos |
